-
News from the Pacific Northwest Node
Congratulations to Judith Tsui, MD, MPH, member of the CTN Pacific Northwest Node, who has just been named the President-Elect of CPDD (College on Problems of Drug Dependence)! Dr. Tsui is a Professor of Medicine at the University of Washington, based at Harborview Medical Center and Evergreen Treatment Services, Director of the UW GIM Substance Use Research and Education (SURE) Unit, Associate Director of the Addiction Medicine Fellowship at the UW, Director of the UW/Fred Hutch Center for AIDS Research Substance Scientific Working Group, and PI/Director of the NIH/NIDA R25-funded UW Medical Student Addiction Research (“MedStAR”) Program. Each director on the CPDD board offers a unique perspective that works to strengthen the strategic direction of the organization and help it continue to grow, innovate, and serve its community with purpose. We know Dr. Tsui will be an invaluable asset to the board and are looking forward to how this new experience will inform the work of the Pacific Northwest Node as well! Read more about the incoming board members here!
-
Recording available! CTN Youth SIG Webinar: Implications of Basic Emotion Science for SUD Treatment & Intervention
The CTN Youth SIG hosted the following webinar in March 2025: Implications of basic emotion science for substance use treatment and intervention Presenter: Michelle “Lani” Shiota, Ph.D.Professor, Department of PsychologyDirector, Substance use and Addiction Translational Research Network (SATRN)Arizona State University Dr. Michelle “Lani” Shiota is a Professor of Psychology at ASU conducting research on positive emotions, emotion regulation, and emotion-related mechanisms of health behavior. As Director of SATRN@ASU she guides a network of academic researchers and community partners in promoting community-engaged and interdisciplinary addiction science as well as evidence-based practice. A former junior high science teacher and teen dance instructor, Dr. Shiota also brings a unique perspective on issues related to youth substance use. Dr. Shiota’s presentation delved into implications of basic emotion science for innovative, mechanistic research on substance use prevention, treatment, and harm reduction. Informed by psychology, neuroscience, and addiction science, she highlighted distinct research questions revealed through this lens, as well as opportunities for intervention. Watch the recording here! Posted on April 10, 2025.
-
CTN Library Site May Be Unavailable April 8-9, 2025
The CTN Library website will be undergoing some server upgrades starting in the afternoon of Tuesday, April 8th and may be temporarily unavailable throughout the evening and into the next day. If you have an urgent need for any information or publications from the site, please contact ctnlib@uw.edu for assistance! Posted on April 7, 2025.
-
New CTN SIG: Secondary Data Analysis
We would like to announce the creation of a new Special Interest Group and extend an invitation to all who are interested in participating. The CTN Secondary Data Analysis SIG’s mission is to maximize the scientific knowledge gleaned from each CTN study conducted by standardizing, promoting, and supporting the use of existing CTN data to answer novel research questions. We discuss how to make data access and navigation easier, procedures and best practices for conducting secondary data analyses, and what research questions available data may be able to answer. Please reach out to Jerry Cochran (jerry.cochran@hsc.utah.edu) and Corey Hayes (cjhayes@uams.eduif) for more information! Posted April 3, 2025
-
Learning for Early Careers in Addiction & Diversity (LEAD Program): Apply by April 15, 2025!
The Learning for Early Careers in Addiction and Diversity (LEAD) program offers mentorship and training to postdoctoral fellows and assistant professors who are pursuing independent research careers in substance use and substance use disorder treatment. This support is aimed at individuals from racial and ethnic minoritized groups who are underrepresented among NIH-funded investigators in this field. The LEAD Program uses the NIDA Clinical Trials Network (CTN) as a platform for training early-careerinvestigators. This 3-year training program is based at the University of California, San Francisco (UCSF), and visiting scholars spend three summers in a 4-week intensive program at UCSF. During the academic year, scholars work with their primary mentor to collaborate on substance use and substance use disorder treatment research conducted in the CTN, develop a professional research network, and conduct a pilot study that will serve as a preliminary study for subsequent NIH funding. The program provides travel and housing funds for scholars, as well as pilot study funding. The 2025 summer program begins on July 7th and ends August 1st. The application deadline is April 15, 2025! Learn more and apply here!
-
Fellowship in Addiction Dissemination & Implementation Science – Deadline extended to APRIL 15!
Applications are now being accepted for the 2025–2026 Center for Dissemination and Implementation At Stanford (C-DIAS) Fellowship in Addiction Dissemination & Implementation (D&I) Science. The C-DIAS Fellowship in Addiction Dissemination & Implementation (D&I) Science is for early or mid-career individuals with goals to improve public access to and quality of addiction treatment by leveraging advanced implementation science methods. Submit your application by April 15th, 2025. This year-long mentored learning experience: Activities include monthly, virtual, hour-long lectures; participation in the C-DIAS Research Core sections activities; C-DIAS Virtual Grand Rounds; individualized mentoring; lead authorship opportunities; and support developing an NIH grant application or proposal to solve a health systems problem. The C-DIAS Fellowship is eligible for CME/CE credits. C-DIAS Fellows join an expanding network of individuals engaged in addiction treatment health services and implementation research, all committed to real-world impact. More information about the fellowship can be found on the C-DIAS website or this flyer .
-
News from the Appalachian Node: Updates from the CTN-0139 Co-CARE study
Jane Liebschutz (Appalachian Node), Rebecca Stone (NY Node) and Donna Beers (Boston Medical Center) traveled to Enterprise OR to conduct a site visit at Winding Waters, a federally qualified health center participating in CTN 139-CoCare. The three city slickers enjoyed their first taste of Frontier designation, which is less than 6 people per square mile. The view was stunning with snow capped peaks and a gorgeous river. But what impressed us all was the dedication and smooth running of the clinic. The five physicians and three physician assistants provide primary care, mental health or dental health to 80% of the population in the area. The program joined CTN-139 as part of the Care for Health Initiative, which supports multiple rural primary care research networks around the US. The research team, from both local and more distant locations in Oregon, showed the lead team how coherent leadership and dedication can make a low resourced area function well. We expect them to start patient recruitment by early April at the latest. Also: The Union Community Care site in Lancaster, PA has begun patient recruitment and so far in March have enrolled 6 participants! Posted on March 14, 2025
-
Primary Care SIG Meeting: March 24, 2025 (9-10am PT/12-1pm ET)
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. Primary Care SIG Key Objectives Primary Care SIG Webinars and presentations The Primary Care SIG is led by Joe LeMaster, MD, MPH and Sebastian Tong, MD, MPH, and meets every other month on the 4th Monday of the month from 9-10am PT/12-1pm ET. To join the Primary Care SIG webinar series listserv, please provide your contact information here: https://redcap.link/PCSIG Next Primary Care SIG Meeting Implementing Practice Facilitation to Enhance Chronic Pain and Opioid Management in Older AdultsMarch 24, 2025 9-10am PT/12-1pm ET Zsolt Nagykaldi, PhD, BTh Professor, Director of Research Associate Director of Community Engaged Research Department of Family & Preventive Medicine University of Oklahoma Health Sciences Center Juell Homco, PhD, MPH Assistant Professor Director of Research and Community Analytics Associate Director of Oklahoma Primary Healthcare Improvement CooperativeDepartment of Medical Informatics University of Oklahoma School of Community Medicine Heather Gamble, BS Community Outreach Manager (Practice Facilitator) Oklahoma Shared Clinical and Translational Resources University of Oklahoma Health Sciences Center Register for the Primary Care SIG Meeting here Posted on March 14, 2025
-
Northeast Node Science Series Webinar: Cannabis: Therapeutic Use and Consequences (April 10, 2025,12-1pm ET)
The landscape of cannabis research has sharpened in recent years, with new understandings of what is therapeutically beneficial and what is not. There is a great diversity in cannabis products and nearly as many ways to consume it, with more US states seeking legalization of both medicinal and recreational use. In this presentation, Dr. Alan Budney will review the state of the science related to the clinical efficacy of cannabis use and discuss alternative ways to consider and act on what is known. He will also review the potential consequences of cannabis use for patients with substance use disorders and how we need to consider situational and individual context when evaluating risk and impact of cannabis consumption. Register for the webinar here
-
News from the Pacific Northwest Node
The Pacific Northwest Node will be presenting four CTN-related posters at this year’s College on Problems of Drug Dependence (CPDD) conference in New Orleans (June 14-18, 2025): Authors from the node also have a new paper out, related to CTN-0082: Attitudes Toward and Experience with Naloxone Among People Who Use Drugs in the Southeastern United States. Le MH, et al. International Journal of Drug Policy 2025; 139: 10479. Find it in the CTN Dissemination Library. Posted on March 12, 2025